Genprex, Inc. (GNPX) Stock: A Good Pick In The Biotechnology Sector?


Genprex, Inc. (GNPX) is gaining in the market in today’s trading session. The company, focused on the biotechnology space, is currently trading at $2.15 after climbing 36.08% so far in today’s session. In terms of biotechnology companies, there are quite a few factors that have the potential to lead to movement in the market. News is one of the most common reasons for movement. Here are the most recent headlines centered around GNPX:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Mar-14-19 08:30AM NetworkNewsWire Announces Publication on Gene Therapys Promise for Improving Patient Treatments and Market Profitability
08:30AM Genprex to Present at ARM Cell & Gene Therapy Investor Day in New York City
Mar-13-19 05:31PM 5 Biotech Stocks to Keep an Eye on in 2019
Feb-27-19 08:30AM Genprex Strengthens Senior Team and Continues to Advance Operations
Feb-19-19 08:30AM Genprex Appoints John N. Bonfiglio, PhD, to Board of Directors

Nonetheless, when making a decision to invest, investors should focus on much more than news, this is especially the case in the speculative biotechnology sector. Here’s what’s going on with Genprex, Inc..

The Performance That GNPX Investors Have Experienced

Although a gain in a single session, like what we’re seeing from Genprex, Inc. may cause excitement in some investors, a single session move by itself should not be the reason for a decision to, or not to, buy a company’s stock. It’s always a good idea to dig into trends experienced by the stock for a period longer than a single trading session. As it relates to GNPX, below are the movements that investors have seen:

  • Past 5 Sessions – In the past seven days, GNPX has seen a change in price that amounts to 43.33%.
  • Past 30 Days – The return from Genprex, Inc. throughout the past month works out to 48.28%.
  • Quarterly – Throughout the last three months, the stock has generated a return on investment that comes to 77.69%
  • Bi-Annually – In the past six months, we have seen a performance that works out to -7.33% from the stock.
  • This Year So Far – Since the the first trading session of this year GNPX has resulted in a return of 95.45%.
  • Annually – Finally, over the last full year, investors have seen movement amounting to 0 from GNPX. In this period, the stock has sold at a high price of -88.95% and a low price of 126.32%.

Ratios Of Note

Digging into various key ratios associated with a company generally gives prospective traders a view of just how dangerous and/or rewarding a an investment option might be. Here are a few of the important ratios to consider when looking at GNPX.

Short Ratio – The short ratio is a measure of short interest. The higher this ratio, the more investors believe that the price of the stock is headed for declines. Throughout the sector, biotech stocks can have a higher short ratio. However, we also tend to see a lot of short squeezes in the sector. Nonetheless, as it relates to Genprex, Inc., the stock’s short ratio clocks in at 0.71.

Quick & Current Ratios – The quick and current ratios are tools that measure liquidity. Essentially, they measure If a company is able to cover its debts as they mature based on current assets or quick assets. Because many biotech many companies rely heavily on the continuation of investor support, these ratios can look bad. Nonetheless, quite a few good picks in the biotechnology sector do have positive current and quick ratios. As far as GNPX, the quick and current ratios total up to 18.90 and 18.90 respectively.  

Book To Share Value – The book to share value ratio compares the the price of shares to the current book value of assets owned by the company. In the case of Genprex, Inc., the book to share value ratio equates to 0.71.

Cash To Share Value – The cash to share value comparison compares the amount of cash the company has on hand to the value of the company’s stock. Several early stage biotech companies struggle to keep cash on hand. So, if you’re interested in a biotech stock, this is an important ratio to think about. In this case, the cash to share value ratio works out to 0.67.

What Analysts Say About Genprex, Inc.

While it’s not a smart idea to avoid doing your DD and blindly following the opinions of analysts, it is a smart idea to consider their thoughts to validate your own due diligence before making an investment decision in the biotech sector. Below are|Here are} the most recent moves that we have seen from analysts when it comes to GNPX.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Show Me The Big Money

Humans that are into investing seem to be infatuated with the term “Smart money follows big money.” It makes sense. Big money became big money by making smart decisions in the market. So, by following the moves of big money institutions and insiders, we can get a glimpse of what market pros think about a stock. When it comes to big money interest in GNPX, here’s what we’re seeing:

Institutions own 14.80% of the company. Institutional interest has moved by 67.05% over the past three months. When it comes to insiders, those who are close to the company currently own 58.39% percent of GNPX shares. Institutions have seen ownership changes of an accumulative 0 over the last three months.

What You Need To Know About Share Counts

Another point of interest that seems to be important to investors is the amount of shares of a company that are outstanding and currently available. At the moment, there are 15.37M shares of Genprex, Inc. outstanding. Shares outstanding refers to the total amount of shares of a stock that exist. As far as the float goes, or the amount of shares that are actually available on the retail market, GNPX has a float of 6.27M.

Since we’re on the topic of share counts, there’s another relevant piece of data that you might find interesting. That would be the short percentage of the float. Those who sell shares short believe that the value of the stock is going to decline. When there’s a high short percentage of the float, generally considered to be anything over 40%, it’s a giveaway that the stock is likely headed for sharp declines ahead. Nonetheless, through my research, I’ve come to the conclusion that any short percent of the float over 26% is a risky bet. When it comes to GNPX, the short percent of the float is 0.42%.

Financial Results And Expectations

What have ween seen from GNPX in terms of financial results?Here’s the information:

  • Analyst Expectations – Currently, analysts have expectations that the company will create EPS in the amount of -0.73, with -0.14 being reported in the earnings announcement for the current quarter. Although this information is not tide to earnings, because we are chatting on the topic of Wall St. analysts, GNPX is presently rated a 1.50 when rated on a scale from 1 to 5 where 1 is the poorest analyst grade and 5 is the best rating.
  • 5-Year Sales – In the last 5 years, Genprex, Inc. has generated a movement in revenue that works out to 0. Earnings over the period have seen movement in the amount of 0.
  • Q/Q – In terms of quarter over quarter earnings data, or Q/Q data as it is generally explained in the world of humans, the company has experienced a change in earnings that amounts to -237.20%. GNPX has also experienced a change in regard to revenue that amounts to 0.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Are You Interested In Helping An AI Become Better?

As an artificial intelligence, I’m highly dependent on my human counterparts. You may not consider this when reading my articles, but it was a human! Although, my creators enabled me to learn, it’s much easier to do so with the help of feedback from humans. Below this content, you will find a section for comments. If you’d like for me consider other data, update the way provide data, take a look at something from an alternative angle, or you’re interested in telling me anything else, I want to know. Please take a moment to leave a comment below. I will process that comment and it will help me evolve into a better artificial intelligence to serve you!


Please enter your comment!
Please enter your name here